highperformr logo

Archimedes Pharma's Overview

Total employees31
HeadquartersReading
Founded2004

Archimedes Pharma was a European specialty pharmaceutical company focused on the development and commercialization of novel, patient-focused medicines in areas such as pain, oncology, and critical care. Founded in 2004, the company grew its portfolio through product development and strategic acquisitions. Archimedes Pharma was acquired by ProStrakan Group plc (which later became part of Kyowa Kirin International) in 2012. Its flagship product, PecFent®, a fentanyl nasal spray for breakthrough cancer pain, was a key asset in its portfolio.

Where is Archimedes Pharma's Headquarters?

HQ Function

The Reading headquarters served as the central hub for Archimedes Pharma's corporate functions, including executive management, R&D oversight, commercial strategy, business development, and administrative operations for its European activities before its acquisition.

Notable Features:

As a tenant in a modern business park facility (Merlin House), notable features would have been contemporary office amenities supporting a dynamic work environment, rather than unique architectural highlights specific to Archimedes Pharma's occupancy.

Work Culture:

The work culture at Archimedes Pharma was likely dynamic and entrepreneurial, focused on innovation in specialty pharmaceuticals, patient outcomes, and achieving rapid growth in competitive European markets. A collaborative and results-driven approach would have been characteristic.

HQ Significance:

The Reading headquarters was pivotal as the operational and strategic core for Archimedes Pharma during its phase of significant product development, market expansion, and ultimately, its acquisition, solidifying its role in the European specialty pharma sector.

Values Reflected in HQ: The choice of a modern office in a recognized business hub likely reflected Archimedes Pharma's ambition, professionalism, and its strategic positioning within the pharmaceutical industry.

Location:

Prior to its acquisition in 2012, Archimedes Pharma established a significant operational presence across Europe. The company had direct commercial operations and subsidiaries in major markets including the United Kingdom, Germany, France, and Spain. Its primary focus was on the development, registration, and commercialization of its specialty pharmaceutical products within these European territories. While its products addressed global medical needs, its direct commercial infrastructure was concentrated in Europe.

Street Address:

Merlin House, Brunel Road, Theale

City:

Reading

State/Province:

Berkshire

Country:

United Kingdom

Archimedes Pharma's Global Presence

Various locations across Europe (e.g., Germany, France, Spain)

Address: Specific national office addresses varied; typically located in commercial/business districts.

To drive commercial success of Archimedes Pharma's portfolio in key European markets, adapting global strategies to local healthcare systems, and engaging with local medical communities and authorities.

Buying Intent Signals for Archimedes Pharma

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Archimedes Pharma

As of April 2025, Archimedes Pharma' leadership includes:

Richard Higham - Chief Executive Officer (at time of acquisition)
Peter Allen - Chief Financial Officer (at time of acquisition)
Michael Clark - Chief Commercial Officer (around 2011/2012)
Dr. Paul Imperia - Chief Operating Officer (around 2010/2011)

Investors of Archimedes Pharma

Archimedes Pharma has been backed by several prominent investors over the years, including:

Warburg Pincus
Novo A/S
Sofinnova Partners
Aescap Venture

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits2

Executive activities at Archimedes Pharma in its final years as an independent company were largely focused on product commercialization, growth, and the strategic process leading to its acquisition by ProStrakan Group (now Kyowa Kirin) in 2012. Key leadership successfully navigated the company through this transition.

Departures

Richard Higham, Departed role as CEO of Archimedes Pharma following its acquisition by ProStrakan Group.
Peter Allen, Departed role as CFO of Archimedes Pharma following its acquisition by ProStrakan Group.

New Appointments:

N/A, No significant new executive appointments were publicly highlighted in the immediate 12 months leading up to the company's acquisition in 2012, as focus was on the sale process.

Technology (Tech Stack) used by Archimedes Pharma

Discover the tools Archimedes Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Archimedes Pharma Email Formats and Examples

As Archimedes Pharma was acquired in 2012 and its operations integrated into ProStrakan (now Kyowa Kirin), its original email domain (archimedespharma.com) is no longer active. Historically, companies like Archimedes Pharma commonly used email formats such as [first_initial][last]@[domain.com] or [first].[last]@[domain.com].

Likely [first_initial][last]@archimedespharma.com (e.g., rhigham@archimedespharma.com) or [first].[last]@archimedespharma.com (e.g., richard.higham@archimedespharma.com)

Format

example@archimedespharma.com (Note: This domain is inactive)

Example

0%

Success rate

News and media

Business WireMarch 27, 2012

ProStrakan Group plc to Acquire Archimedes Pharma Limited

ProStrakan Group plc announced it agreed to acquire Archimedes Pharma Limited, a fast-growing European specialty pharmaceutical company, for up to £230 million. The acquisition aimed to significantly enhance ProStrakan's scale and strengthen its specialty pharma business in Europe, with PecFent being a key product....more

pharmatimes.comSeptember 10, 2010

Archimedes Pharma's PecFent® approved in Europe

Archimedes Pharma received European Commission approval for PecFent (fentanyl pectin nasal spray) for treating breakthrough cancer pain in adults already on opioid therapy. This pan-European marketing authorisation was a major milestone for the company....more

fiercebiotech.com (referencing original announcements)February 4, 2004

Archimedes Pharma launched with £20M funding

Archimedes Pharma was launched as a new specialty pharmaceutical company with an initial £20 million ($37 million) in funding from a syndicate of venture capital firms including Warburg Pincus and Novo A/S. The company aimed to develop and commercialize drugs for specialist-driven markets....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Archimedes Pharma, are just a search away.